Table 3 Lung function and respiratory morbidity by RSV and LRTI status.
| RSV symptomatic LRTI group (1) | RSV negative symptomatic LRTI group (2) | No LRTI symptoms group (3) | p value | ||
|---|---|---|---|---|---|
| (n = 15) | (n = 15) | (n = 9) | 1 v 2 | 1 v 3 | |
| Lung function | |||||
| Postmenstrual age (wk) | 35.8 (0.6) | 36.0 (0.7) | 35.8 (0.9) | 1.000 | 1.000 |
| Weight (kg) | 2.13 (0.38) | 2.30 (0.44) | 2.54 (0.49) | 0.900 | 0.091 |
| FRC (ml/kg) | 21.9 (4.2) | 19.7 (1.9) | 23.1 (3.5) | 1.000 | 1.000 |
| Crs (ml/cm H2O/kg) | 0.98 (0.47) | 0.75 (0.33) | 1.2 (0.51) | 1.000 | 0.959 |
| Rrs (cm H2O/l/s) | 126.1 (62.1) | 100.6 (28.9) | 80.4 (19.9) | 0.173 | 0.058 |
| Respiratory morbidity at one year | |||||
| Cough (days) | 7 (0–31) | 4 (0–14) | 0 (0–5) | 0.292 | 0.072 |
| Wheeze (days) | 5 (0–22) | 0 (0–7) | 0 (0–5) | 0.125 | 0.084 |